Literature DB >> 24053416

A longitudinal study evaluating the effect of exacerbations on physical activity in patients with chronic obstructive pulmonary disease.

Mohsin Ehsan1, Rana Khan, Dorothy Wakefield, Asher Qureshi, Lindsey Murray, Richard Zuwallack, Nancy Kline Leidy.   

Abstract

BACKGROUND: Physical inactivity is common in stable chronic obstructive pulmonary disease (COPD) and independently predicts poor outcomes. Longitudinal assessments of physical activity in outpatients with COPD, covering periods of stability and exacerbations, have not been evaluated previously.
METHODS: Patients with clinically stable COPD and a history of two or more clinical exacerbations in the preceding 12 months were recruited. Physical activity was measured using a triaxial accelerometer worn continuously on the nondominant wrist. Mean minutes per day of higher level physical activity was the primary outcome variable. Symptom-defined exacerbations were assessed using the 14-item Exacerbations of Chronic Pulmonary Disease Tool (EXACT) daily dairy. Clinically reported exacerbations were also captured. Minutes per day of higher level physical activity during exacerbation and nonexacerbation days were compared, using a mixed model analysis.
MEASUREMENTS AND MAIN RESULTS: Seventeen patients were monitored for 135 ± 18 days. Nine were male with a mean age of 63 ± 12 years and mean FEV1 of 52 ± 20%. Fifteen patients had 27 symptom (EXACT)-defined exacerbations, including 9 that were also clinically reported. Patients spent fewer minutes per day at a higher level physical activity level during exacerbation days than nonexacerbation days: 131 ± 14 versus 157 ± 14 minutes (P < 0.0001). The greatest reduction in physical activity was during the first week of the exacerbation; activity remained low for approximately 2 weeks after exacerbation resolution.
CONCLUSIONS: Physical activity decreased significantly during exacerbations. Reduction in activity occurs early during an exacerbation and persists for about 2 weeks after symptomatic recovery.

Entities:  

Mesh:

Year:  2013        PMID: 24053416     DOI: 10.1513/AnnalsATS.201304-100OC

Source DB:  PubMed          Journal:  Ann Am Thorac Soc        ISSN: 2325-6621


  14 in total

1.  The Short-term Impact of Symptom-defined COPD Exacerbation Recovery on Health Status and Lung Function.

Authors:  Lindsey T Murray; Nancy K Leidy
Journal:  Chronic Obstr Pulm Dis       Date:  2018-01-24

Review 2.  Relevance of nutritional support and early rehabilitation in hospitalized patients with COPD.

Authors:  Ghislaine Gayan-Ramirez
Journal:  J Thorac Dis       Date:  2018-05       Impact factor: 2.895

3.  Can Commercially Available Pedometers Be Used For Physical Activity Monitoring In Patients With COPD Following Exacerbations?

Authors:  Valentin Prieto-Centurion; Nina Bracken; Lourdes Norwick; Farhan Zaidi; Amelia A Mutso; Victoria Morken; David B Coultas; Cynthia S Rand; David X Marquez; Jerry A Krishnan
Journal:  Chronic Obstr Pulm Dis       Date:  2016

Review 4.  Optimizing nonpharmacological management following an acute exacerbation of chronic obstructive pulmonary disease.

Authors:  Samantha L Harrison; Roger Goldstein; Laura Desveaux; Verity Tulloch; Dina Brooks
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2014-10-29

5.  Sleep Quality Prediction From Wearable Data Using Deep Learning.

Authors:  Aarti Sathyanarayana; Shafiq Joty; Luis Fernandez-Luque; Ferda Ofli; Jaideep Srivastava; Ahmed Elmagarmid; Teresa Arora; Shahrad Taheri
Journal:  JMIR Mhealth Uhealth       Date:  2016-11-04       Impact factor: 4.773

6.  The Activities of Daily Living after an Acute Exacerbation of Idiopathic Pulmonary Fibrosis.

Authors:  Kazuya Koyama; Susumu Sakamoto; Takuma Isshiki; Hiroshige Shimizu; Atsuko Kurosaki; Sakae Homma
Journal:  Intern Med       Date:  2017-09-25       Impact factor: 1.271

7.  Daily activity during stability and exacerbation of chronic obstructive pulmonary disease.

Authors:  Ayedh D Alahmari; Anant R C Patel; Beverly S Kowlessar; Alex J Mackay; Richa Singh; Jadwiga A Wedzicha; Gavin C Donaldson
Journal:  BMC Pulm Med       Date:  2014-06-02       Impact factor: 3.317

Review 8.  Cachexia in chronic obstructive pulmonary disease: new insights and therapeutic perspective.

Authors:  Karin J C Sanders; Anita E M Kneppers; Coby van de Bool; Ramon C J Langen; Annemie M W J Schols
Journal:  J Cachexia Sarcopenia Muscle       Date:  2015-09-07       Impact factor: 12.910

9.  The association between daily exacerbation symptoms and physical activity in patients with chronic obstructive pulmonary disease.

Authors:  Sarah Crook; Gilbert Büsching; Stephan Keusch; Stephan Wieser; Alexander Turk; Martin Frey; Milo A Puhan; Anja Frei
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2018-07-18

Review 10.  Use of Mobile Devices to Measure Outcomes in Clinical Research, 2010-2016: A Systematic Literature Review.

Authors:  Brian Perry; Will Herrington; Jennifer C Goldsack; Cheryl A Grandinetti; Kaveeta P Vasisht; Martin J Landray; Lauren Bataille; Robert A DiCicco; Corey Bradley; Ashish Narayan; Elektra J Papadopoulos; Nirav Sheth; Ken Skodacek; Komathi Stem; Theresa V Strong; Marc K Walton; Amy Corneli
Journal:  Digit Biomark       Date:  2018-01-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.